{
    "nctId": "NCT01219075",
    "briefTitle": "Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer",
    "officialTitle": "Soy Treatment for High-risk Women",
    "overallStatus": "COMPLETED",
    "conditions": "BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Number of participants with reduced MRI volume (MRIV)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women at high risk for breast cancer, defined as any of the following groups:\n* Five year Gail risk \\> 1.7%\n* Known BRCA1/BRCA2 mutation carrier\n* Family history consistent with hereditary breast cancer\n* Prior biopsy exhibiting atypical hyperplasia or lobular carcinoma in situ (LCIS)\n* History of invasive breast cancer or ductal carcinoma in situ (DCIS) and have completed standard therapy including tamoxifen/aromatase inhibitor or will not be treated with tamoxifen/aromatase inhibitor\n* Signed Informed Consent\n\nExclusion Criteria:\n\n* Metastatic breast cancer\n* Undergoing treatment (chemotherapy, radiation, or SERMs)\n* Pregnancy or breast-feeding, or planning to become pregnant within one year prior to study entry\n* Regular soy consumers (i.e., \\< once per week of soy food, soy supplements or other products)\n* Known food allergies such as to soy or nuts\n* Not willing to avoid soy foods/supplements during study period\n* Current users of exogenous hormones or oral contraceptive or planning to use exogenous hormones during the duration of the study\n* Cannot stop taking aspirin or NSAIDs within a week of breast biopsy\n* Active participant in other ongoing trials",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}